Pallas Capital Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
6,333
+62
| +1% | +$13.6K | 0.05% | 257 |
|
|
2025
Q1 | $1.4M | Sell |
6,271
-30
| -0.5% | -$6.72K | 0.06% | 240 |
|
|
2024
Q4 | $2.06M | Buy |
6,301
+8
| +0.1% | +$2.62K | 0.09% | 155 |
|
|
2024
Q3 | $2.08M | Sell |
6,293
-1
| -0% | -$331 | 0.09% | 151 |
|
|
2024
Q2 | $1.99M | Buy |
6,294
+5
| +0.1% | +$1.58K | 0.09% | 153 |
|
|
2024
Q1 | $2.49M | Sell |
6,289
-6
| -0.1% | -$2.37K | 0.1% | 142 |
|
|
2023
Q4 | $2.22M | Sell |
6,295
-6
| -0.1% | -$2.11K | 0.12% | 134 |
|
|
2023
Q3 | $2.02M | Buy |
6,301
+11
| +0.2% | +$3.52K | 0.12% | 138 |
|
|
2023
Q2 | $2.41M | Buy |
6,290
+15
| +0.2% | +$5.75K | 0.11% | 114 |
|
|
2023
Q1 | $2.33M | Sell |
6,275
-3
| -0% | -$1.12K | 0.22% | 88 |
|
|
2022
Q4 | $1.63M | Sell |
6,278
-57
| -0.9% | -$14.8K | 0.16% | 105 |
|
|
2022
Q3 | $1.33M | Buy |
6,335
+2,000
| +46% | +$419K | 0.15% | 110 |
|
|
2022
Q2 | $1.36M | Hold |
4,335
| – | – | 0.19% | 95 |
|
|
2022
Q1 | $1.65M | Buy |
+4,335
| New | +$1.65M | 0.21% | 90 |
|